Recent news on Vigamox

Drug Comp Secretly Track Doctors' Rx  -  May 22, 2007
Free Market News Network,In the letter, the salesperson wrote that Thakkar was causing his patients to miss more days of school than they would if he put them on Vigamox,

Legislation targets data-mining by drug marketers  -  May 24, 2007
Monterey County Herald,In the letter, the salesperson wrote that Thakkar was causing his patients to miss more days of school than they would if he put them on Vigamox,

An Eye-Opening Potential Acquisition  -  May 2, 2007
Motley FoolIn addition, AzaSite belongs to the macrolide class of antibiotics; leading competitors Vigamox, from Alcon (NYSE: ACL), and Zymar, from Allergan (NYSE:

Alcon’s First Quarter Sales Rise 14.3 Percent  -  Apr 25, 2007
Business Wire (press release),Sales of infection/inflammation products rose 15.5 percent as a result of market share gains by Vigamox ® ophthalmic solution in the United States and solid

Alcon’s First Quarter Sales Rise 14.3 Percent  -  26 Apr 2007
Business Wire (press release),Sales of infection/inflammation products rose 15.5 percent as a result of market share gains by Vigamox ® ophthalmic solution in the United States and solid

Alcon's First Quarter Sales Rise 14.3 Percent  -  26 Apr 2007
American Digital Networks (press release),Sales of infection/inflammation products rose 15.5 percent as a result of market share gains by Vigamox(R) ophthalmic solution in the United States and

Dopamine in identified among der the tracers.  -  Apr 9, 2007
Journal lycéen,The dose by direct attracting and Vigamox the witness aspirin. Vietnam began consumed state Efudex fiestas or cited on nurses. Hughes et none reported to

Fluoroquinolones to prevent postoperative keratitis and ...  -  Apr 10, 2007
OSN SuperSite (subscription),Human cornea and aqueous humor concentrations of moxifloxacin and gatifloxacin following topical ocular dosing with Vigamox solution or Zymar.

Fluoroquinolones penetrated cornea when delivered via collagen shields  -  Feb 21, 2007
OSN SuperSite (subscription),After 3 hours, aqueous humor samples showed high concentrations of antibiotics: 3.1 µg/mL for Vigamox and 2.3 µg/mL for gatifloxacin.

Alcon's Fourth Quarter Sales Rise 16.1 Percent  -  Feb 8, 2007
PharmaLive.com (press release),Sales of anti-infection and anti-inflammation products rose 22.2 percent to $183.3 million, mainly due to US share gains for Vigamox(R) ophthalmic solution

Foro de Shell Security - Seguridad informática  Oct 27, 2006
These c vidaza lls produce inhibitory cytokines, such as gamm vigamox -interferon and tumor necrosis factor, which can suppres vincristine ing progenitor-cell ... -Shell Security, Alcon’s Third Quarter Sales Rise 12.4 Percent  Oct 23, 2006
Sales of infection and inflammation products rose 12.6 percent to $176.7 million, mainly due to US share gains for Vigamox ® ophthalmic solution and Nevanac ... -Business Wire (press release), Vegamox(TM) (Moxifloxacin Hydrochloride Ophthalmic Solution) ...  Jul 27, 2006
...bacterial eye diseases.". Vegamox solution is currently approved as Vigamox™ solution in more than 40 countries around the world. -DG News

Alcon's VEGAMOX(TM) Ophthalmic Solution Approved in Japan for Eye ...  Jul 26, 2006
...diseases.". VEGAMOX(TM) solution is currently approved as VIGAMOX(R) solutionin more than 40 countries around the world. Alcon, Inc. ... -Finanzen.net



Moxifloxacin Concentrations Higher Than Gatifloxacin in Eye ...  May 4, 2006
FT. LAUDERDALE, FL -- May 4, 2006 -- Higher antimicrobial activity and concentration of moxifloxacin (Vigamox) when compared to gatifloxacin (Zymar) may help ... - DG News

(BW) Alcon's First Quarter Sales Rise 8.1 Percent, Net Earnings ...  Apr 24, 2006
Sales of infection/inflammation products rose 8.4 percent led by increased penetration of Vigamox(R) ophthalmic solution in the US and the contribution to ... - Houston Chronicle





Alcon sues Teva over Vigamox patents  Apr 5, 2006
...on charges that Teva's application to sell a generic version of its Vigamox drug violates its licensed patents. Vigamox is used ... - BusinessWeek

Alcon Sues Teva Over Vigamox Patents  Apr 5, 2006
...on charges that Teva's application to sell a generic version of its Vigamox drug violates its licensed patents. Vigamox is used ... - Houston Chronicle

Alcon Files Patent Infringement Suit Against Teva Pharmaceuticals  Apr 5, 2006
ANDA) to the US Food and Drug Administration (FDA)requesting approval to manufacture and sell a generic version ofAlcon's VIGAMOX(R) (moxifloxacin HCI ... - Finanzen.net

Alcon Files Patent Infringement Suit Against Teva's ANDA For ...  Apr 5, 2006
The lawsuit relates to Teva's submission of an ANDA seeking approval to manufacture a generic version of Alcon's VIGAMOX before the expiration of the three ... - Trading Markets

Alcon To Strongly Defend Its Patents And Product Against Teva's ...  Apr 5, 2006
...submission of an Abbreviated New Drug Application, ANDA, to the FDA requesting approval to manufacture and sell a generic version of Alcon's VIGAMOX prior to ... - Trading Markets

Alcon, Bayer sue Teva over generic eye treatment  Apr 5, 2006
...(TEVA.O: Quote, Profile, Research)(TEVA.TA: Quote, Profile, Research), responds to Teva's push to sell a generic version of Alcon's Vigamox. ... - Reuters

Alcon, Bayer file patent infringement lawsuit against generic drug ...  Apr 5, 2006
Alcon (NYSE: ACL) claims a request by Teva to the US Food and Drug Administration to make and sell a generic version of Alcon's Vigamox violates two Bayer ... - Dallas Business Journal

AFX NEWS BRIEFING: Pharmaceuticals and chemicals highlights to 09 ...  Apr 6, 2006
...complaint in a US district court against Teva. The suit is in response to. version of Alcon's Vigamox, which is used to treat eye infections. Alcon said it. - Forbes

Alcon, Bayer sue Teva over generic eye treatment  Apr 5, 2006
...responds to Teva's push to sell a generic version of Alcon's Vigamox. Teva has submitted an Abbreviated New Drug Application (ANDA ... - ABC News

Allergan settle patent dispute with Alcon  Mar 10, 2006
...ingredient in Alphagan. The second suit alleged that Alcon's Vigamox product infringed on Allergan eye antibiotics. Under the terms ... - Bizjournals.com

Allergan, Alcon Settle Patent Charges  Mar 9, 2006
Alcon said it believes the lawsuit was meant to target its Vigamox product. Neither company disclosed details concerning this settlement. ... - MSN Money

Alcon and Allergan Reach Agreement on Brimonidine 0.15% Patent ...  Mar 9, 2006
Alcon believes this suit was intended to target Vigamox(R) (0.5% moxifloxacin HCl ophthalmic solution), Alcon's leading ophthalmic ocular antibiotic in the US. ... - Genetic Engineering News

Allergan, Alcon settle patent charges  Mar 9, 2006
...for an eye antibiotic. Alcon said it believes the lawsuit was meant to target its Vigamox product. Allergan spokeswoman Caroline ... - BusinessWeek



Alcon's Fourth Quarter Sales Rise 10.7 Percent  Feb 8, 2006
Sales of infection/inflammation products rose 13.6 percent led by increased sales of Vigamox(R) ophthalmic ... Vigamox(R) is licensed to Alcon fromBayer AG. - Finanzen.net,

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional